Roundtable 7: Patient and Public Perspectives as a Barrier to Adoption of Cell and Gene Therapies 

1.) What role has the media’s coverage of the cost of cell and gene therapies played in its adoption? 

2.) What level of information needs to be provided to patients and the general public regarding their the logistical lift and various technologies that are used to create these therapies?  

3.) What can patients and patient advocacy groups do to connect directly with insurance providers and PBM’s to understand the complexity of the the delivery of these treatments 

4.) Given the novelty of these transformative therapies what can be done to drive collaboration and data sharing to move the industry forward? 

Moderated by: George Eastwood, Board Chair, Interim Executive Director, Emily Whitehead Foundation